Success Metrics

Clinical Success Rate
65.6%

Based on 21 completed trials

Completion Rate
66%(21/32)
Active Trials
3(6%)
Results Posted
71%(15 trials)
Terminated
11(22%)

Phase Distribution

Ph phase_4
11
22%
Ph not_applicable
9
18%
Ph phase_1
9
18%
Ph early_phase_1
1
2%
Ph phase_2
14
27%
Ph phase_3
7
14%

Phase Distribution

10

Early Stage

14

Mid Stage

18

Late Stage

Phase Distribution51 total trials
Early Phase 1First-in-human
1(2.0%)
Phase 1Safety & dosage
9(17.6%)
Phase 2Efficacy & side effects
14(27.5%)
Phase 3Large-scale testing
7(13.7%)
Phase 4Post-market surveillance
11(21.6%)
N/ANon-phased studies
9(17.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

21 of 35 finished

Non-Completion Rate

40.0%

14 ended early

Currently Active

3

trials recruiting

Total Trials

51

all time

Status Distribution
Active(6)
Completed(21)
Terminated(14)
Other(10)

Detailed Status

Completed21
Terminated11
unknown8
Not yet recruiting3
Withdrawn3
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
51
Active
3
Success Rate
65.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.0%)
Phase 19 (17.6%)
Phase 214 (27.5%)
Phase 37 (13.7%)
Phase 411 (21.6%)
N/A9 (17.6%)

Trials by Status

terminated1122%
unknown816%
recruiting24%
not_yet_recruiting36%
completed2141%
active_not_recruiting12%
suspended24%
withdrawn36%

Recent Activity

Clinical Trials (51)

Showing 20 of 51 trialsScroll for more
NCT07158437Phase 1

Phase 1 Study of SL-325 in Healthy Volunteers

Active Not Recruiting
NCT07460518Phase 4

Tranexamic Acid for Bleeding Reduction During TURP Surgery

Not Yet Recruiting
NCT07421817Not Applicable

Dexamethasone for Prevention of Postoperative Vomiting After Laparoscopic Gynecologic Surgery

Completed
NCT07202000Phase 2

EXercise and Activin Inhibition to Modulate InflammatioN Effects on Heart Failure and Cognition (EXAMINE-HFC)

Not Yet Recruiting
NCT07280858Phase 1

A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.

Recruiting
NCT07237880Not Applicable

Use of Papaverine to Shorten the Second Stage/Duration of Labor in Pregnant Women After Cervical Ripening by Double-balloon Catheter

Recruiting
NCT05012943Phase 2

The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01)

Completed
NCT07146087Early Phase 1

Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis

Suspended
NCT04876937Not Applicable

Low-Dose Dexmedetomidine for Delirium Prevention in Mechanically Ventilated Septic Patients

Terminated
NCT03172897Phase 4

Low-dose Dexmedetomidine in Mechanically Ventilated ICU Patients

Suspended
NCT06886230Phase 4

Ondansetron vs. Dexamethasone for Postoperative Nausea

Completed
NCT06863220Not Applicable

Intravesical Ozone Therapy for Interstitial Cystitis/Bladder Pain Syndrome

Not Yet Recruiting
NCT02826681Phase 2

Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia

Terminated
NCT05540665Phase 2

Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN)

Terminated
NCT05592418Phase 2

Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions

Completed
NCT05501522Phase 3

Immunogenicity and Safety Study of Heterologous Booster Vaccination of a SARS-CoV-2 Recombinant Protein Nanoparticle Vaccine(GBP510) Adjuvanted with AS03 in Adults Aged 18 Years and Older

Completed
NCT03029442Phase 4

The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury

Terminated
NCT03093064Phase 1

Inflammatory Response In Schizophrenia

Completed
NCT05652543Phase 2

A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine

Completed
NCT03705962Phase 3

Locally Applied Antibiotics for Infection Prophylaxis in Treatment of Open Fractures

Terminated

Drug Details

Intervention Type
OTHER
Total Trials
51